SOCRA CCRP — Certified Clinical Research Professional

Access More Questions
According to 21 CFR 312.32, what is the maximum timeframe within which a sponsor must report an unexpected fatal or life-threatening suspected adverse reaction to the FDA?
Correct Answer:
7 calendar days after the sponsor's initial receipt of the information.

Access more questions from this quiz

Continue to SOCRA CCRP — Certified Clinical Research Professional for more practice questions and the full quiz experience.

Access More Questions